BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19207177)

  • 1. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.
    Ruzagira E; Wandiembe S; Bufumbo L; Levin J; Price MA; Grosskurth H; Kamali A
    Trop Med Int Health; 2009 Feb; 14(2):196-203. PubMed ID: 19207177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
    Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
    Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
    Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
    Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
    BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    Capitine IPU; Macicame IB; Uanela AM; Bhatt NB; Yates A; Milazzo M; Nwoga C; Crowell TA; Michael NL; Robb ML; Jani IV; Kroidl A; Polyak CS; De Schacht C;
    PLoS One; 2021; 16(12):e0260126. PubMed ID: 34855790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.
    Kitonsa J; Kamacooko O; Bahemuka UM; Kibengo F; Kakande A; Wajja A; Basajja V; Lumala A; Ssemwanga E; Asaba R; Mugisha J; Pierce BF; Shattock R; Kaleebu P; Ruzagira E
    PLoS One; 2021; 16(5):e0251992. PubMed ID: 34043693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
    Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.
    Kiwanuka N; Ssetaala A; Mpendo J; Wambuzi M; Nanvubya A; Sigirenda S; Nalutaaya A; Kato P; Nielsen L; Kaleebu P; Nalusiba J; Sewankambo NK
    J Int AIDS Soc; 2013 Jul; 16(1):18621. PubMed ID: 23880102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
    Dong Y; Shen X; Guo R; Liu B; Zhu L; Wang J; Zhang L; Sun J; Zhang X; Xu J
    PLoS One; 2014; 9(11):e111321. PubMed ID: 25372044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group.
    Périssé AR; Schechter M; Moreira RI; do Lago RF; Santoro-Lopes G; Harrison LH
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):459-63. PubMed ID: 11141246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
    PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
    PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Connochie D; Tingler RC; Bauermeister JA
    Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.
    McGrath JW; George K; Svilar G; Ihler E; Mafigiri D; Kabugo M; Mugisha E
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):381-8. PubMed ID: 11468427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India.
    Suhadev M; Nyamathi AM; Swaminathan S; Suresh A; Venkatesan P
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):217-24. PubMed ID: 19239362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.
    Iseselo MK; Tarimo EAM; Sandstrom E; Kulane A
    Biomed Res Int; 2020; 2020():8507981. PubMed ID: 32714988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to participate in South African HIV vaccine trials--concerns of medical professionals in the Western Cape.
    Moodley K; Barnes J; van Rensburg EJ; Myer L
    S Afr Med J; 2002 Nov; 92(11):904-6. PubMed ID: 12506594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.